LXRX Q2 2018 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M+14.1% YoY

Gross Profit

$13M93.9% margin

Operating Income

-$30M-221.3% margin

Net Income

-$35M-252.4% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

-45.4%

Cash Flow

Operating Cash Flow

-$53M

Free Cash Flow

-$53M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$333M

Total Liabilities

$338M

Stockholders' Equity

-$5M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$12M	+14.1%
Gross Profit	$13M	$12M	+12.1%
Operating Income	-$30M	-$34M	+10.2%
Net Income	-$35M	-$35M	+1.0%